Farmacia y Biotecnología Medicina y Salud

Oncologix Tech Acquires Angels of Mercy; Gains Leading Healthcare Service Company

Internacional (Marketwired, 05 de Agosto de 2013) Oncologix Tech Inc. (OTCQB: OCLG), announced today the Company has purchased 100% of the common stock of Angels of Mercy, Inc., a leader in the Personal Care Attendant (PCA) healthcare services industry. 

Internacional (Marketwired, 05 de Agosto de 2013) Oncologix Tech Inc. (OTCQB: OCLG), announced today the Company has purchased 100% of the common stock of Angels of Mercy, Inc., a leader in the Personal Care Attendant (PCA) healthcare services industry. Wayne Erwin, OCLG's Chief Executive Officer, remarked, "Oncologix is extremely delighted to complete the acquisition of Angels of Mercy. Angels is the leading healthcare services company in the State of Louisiana providing PCA services to over 200 active clients, with 168 employees and $2.9 million in annual revenues. The acquisition establishes the foundation for our healthcare services division and confirms the strategic mission of the company: to acquire medical device and healthcare services-related companies."

Angels of Mercy began its healthcare service operations in 2001 with offices in Alexandria and Lafayette, Louisiana. As a healthcare service provider, Angels of Mercy delivers education and training to Personal Care Assistants who provide routine health and personal care support and assistance with Activities of Daily Living (ADL) to patients with physical impairments or disabilities in private homes, nursing care facilities, and other residential settings. Angels of Mercy holds both PCA-Medicaid Waiver Provider and Residential Rehabilitation/Supervised Independent Living (SIL) licenses issued by the Division of Licensing and Certification of the Department of Social Services and the Louisiana Department of Health and Hospitals. Licenses are issued to Angels of Mercy for Region 4 and Region 6 covering 12 parishes within the State of Louisiana.

Oncologix is an acquisitive diversified medical device and healthcare holding company. For its customers, Oncologix provides FDA approved medical devices and state licensed healthcare services. For its shareholders, Oncologix acquires profitable operations that build, maintain and nourish shareholder value. The Company's corporate mission is to be the best small cap medical device and healthcare holding company in North America.

This press release may contain forward-looking statements, made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Company's expectations, among other things, are dependent upon economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, its ability to operate its subsidiary companies effectively, need for and availability of more capital as well as other uncontrollable or unknown factors which are more fully disclosed in the Company's 8-K on file with the Securities and Exchange Commission.

 

Contact Information

CONTACT INFORMATION

Wayne Erwin
CEO
Email Contact
318-451-9543

Investor Relations:
Jack Eversull
President
The Eversull Group, Inc.
972-571-1624
214-469-2361 fax
Email Contact

 

FUENTE: MARKETWIRED

About the author

admin